In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on Novartis AG (NOVN – Research Report), with a price ...

Novartis' strong drug pipeline and financials support an 11% annual return by 2027. Learn why NVS stock offers 33% return ...

Genentech and Novartis have teamed up with Food Allergy Research & Education (FARE) to enhance the safety of children with ...

Novartis has committed $7.5 million to an initiative aiming to save 100,000 lives by 2035. The money will launch Zero ...

Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Novartis AG (NOVN – Research Report) today and set a price target of ...

Meghan Markle's As Ever logo includes a tribute to Prince Harry. Inside the symbolism and what the Duchess of Sussex has said ...

For years, social media users have shared what they describe as Netflix's original logo featuring black lettering and a ...

The company has a market capitalization of $215.50 billion, a price-to-earnings ratio of 17.93, a P/E/G ratio of 1.70 and a beta of 0.58. Novartis has a fifty-two week low of $92.35 and a fifty ...

In December 1996, Sandoz and Ciba-Geigy merged to form Novartis in one of the largest corporate mergers in history. Sandoz remained as a subsidiary of Novartis and today develops, manufactures and ...

Novartis ranked overall 1st for corporate reputation in dermatology out of 15 companies for as many as nine of the 12 indicators by skin patient group. Novartis achieved the highest scores in nine ...

DelveInsight's Influenza Vaccine Market Insights report provides the current and forecast market analysis, individual leading ...

A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis (MS) in Finland between 2013 and 2022.